Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0699790 (
colon cancer
)
28,837
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The initiation of centrosome duplication is regulated by the Plk4/STIL/hsSAS-6 axis; however, the involvement of other centrosomal proteins in this process remains unclear. In this study, we demonstrate that
Cep131
physically interacts with Plk4 following phosphorylation of residues S21 and T205. Localizing at the centriole, phosphorylated
Cep131
has an increased capability to interact with STIL, leading to further activation and stabilization of Plk4 for initiating centrosome duplication. Moreover, we found that
Cep131
overexpression resulted in centrosome amplification by excessive recruitment of STIL to the centriole and subsequent stabilization of Plk4, contributing to centrosome amplification. The xenograft mouse model also showed that both centrosome amplification and
colon cancer
growth were significantly increased by
Cep131
overexpression. These findings demonstrate that
Cep131
is a novel substrate of Plk4, and that phosphorylation or dysregulated
Cep131
overexpression promotes Plk4 stabilization and therefore centrosome amplification, establishing a perspective in understanding a relationship between centrosome amplification and cancer development.
...
PMID:Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability. 3135 34